Global Chronic Urticaria Or Hives Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Country/Region, 2017, 2022 & 2028

2.2 Chronic Urticaria Or Hives Drug Segment by Type

2.2.1 GDC-0853

2.2.2 GSK-2646264

2.2.3 BF-Derm-1

2.2.4 Bilastine

2.2.5 Others

2.3 Chronic Urticaria Or Hives Drug Sales by Type

2.3.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Type (2017-2022)

2.4 Chronic Urticaria Or Hives Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Chronic Urticaria Or Hives Drug Sales by Application

2.5.1 Global Chronic Urticaria Or Hives Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chronic Urticaria Or Hives Drug Sale Price by Application (2017-2022)

3 Global Chronic Urticaria Or Hives Drug by Company

3.1 Global Chronic Urticaria Or Hives Drug Breakdown Data by Company

3.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Company (2020-2022)

3.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2020-2022)

3.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Company (2020-2022)

3.2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2020-2022)

3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Company

3.4 Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chronic Urticaria Or Hives Drug Product Location Distribution

3.4.2 Players Chronic Urticaria Or Hives Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chronic Urticaria Or Hives Drug by Geographic Region

4.1 World Historic Chronic Urticaria Or Hives Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Geographic Region

4.2 World Historic Chronic Urticaria Or Hives Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Country/Region

4.3 Americas Chronic Urticaria Or Hives Drug Sales Growth

4.4 APAC Chronic Urticaria Or Hives Drug Sales Growth

4.5 Europe Chronic Urticaria Or Hives Drug Sales Growth

4.6 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Growth

5 Americas

5.1 Americas Chronic Urticaria Or Hives Drug Sales by Country

5.1.1 Americas Chronic Urticaria Or Hives Drug Sales by Country (2017-2022)

5.1.2 Americas Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022)

5.2 Americas Chronic Urticaria Or Hives Drug Sales by Type

5.3 Americas Chronic Urticaria Or Hives Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chronic Urticaria Or Hives Drug Sales by Region

6.1.1 APAC Chronic Urticaria Or Hives Drug Sales by Region (2017-2022)

6.1.2 APAC Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022)

6.2 APAC Chronic Urticaria Or Hives Drug Sales by Type

6.3 APAC Chronic Urticaria Or Hives Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chronic Urticaria Or Hives Drug by Country

7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Country (2017-2022)

7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022)

7.2 Europe Chronic Urticaria Or Hives Drug Sales by Type

7.3 Europe Chronic Urticaria Or Hives Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chronic Urticaria Or Hives Drug by Country

8.1.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type

8.3 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug

10.3 Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug

10.4 Industry Chain Structure of Chronic Urticaria Or Hives Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chronic Urticaria Or Hives Drug Distributors

11.3 Chronic Urticaria Or Hives Drug Customer

12 World Forecast Review for Chronic Urticaria Or Hives Drug by Geographic Region

12.1 Global Chronic Urticaria Or Hives Drug Market Size Forecast by Region

12.1.1 Global Chronic Urticaria Or Hives Drug Forecast by Region (2023-2028)

12.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chronic Urticaria Or Hives Drug Forecast by Type

12.7 Global Chronic Urticaria Or Hives Drug Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca Plc

13.1.1 AstraZeneca Plc Company Information

13.1.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offered

13.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Plc Main Business Overview

13.1.5 AstraZeneca Plc Latest Developments

13.2 Biofrontera AG

13.2.1 Biofrontera AG Company Information

13.2.2 Biofrontera AG Chronic Urticaria Or Hives Drug Product Offered

13.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biofrontera AG Main Business Overview

13.2.5 Biofrontera AG Latest Developments

13.3 ELORAC, Inc.

13.3.1 ELORAC, Inc. Company Information

13.3.2 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offered

13.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 ELORAC, Inc. Main Business Overview

13.3.5 ELORAC, Inc. Latest Developments

13.4 Faes Farma, SA

13.4.1 Faes Farma, SA Company Information

13.4.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offered

13.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Faes Farma, SA Main Business Overview

13.4.5 Faes Farma, SA Latest Developments

13.5 Genentech, Inc.

13.5.1 Genentech, Inc. Company Information

13.5.2 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offered

13.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Genentech, Inc. Main Business Overview

13.5.5 Genentech, Inc. Latest Developments

13.6 GlaxoSmithKline Plc

13.6.1 GlaxoSmithKline Plc Company Information

13.6.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offered

13.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Plc Main Business Overview

13.6.5 GlaxoSmithKline Plc Latest Developments

13.7 J Uriach Y Compania, S.A.

13.7.1 J Uriach Y Compania, S.A. Company Information

13.7.2 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offered

13.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 J Uriach Y Compania, S.A. Main Business Overview

13.7.5 J Uriach Y Compania, S.A. Latest Developments

13.8 Mabtech Limited

13.8.1 Mabtech Limited Company Information

13.8.2 Mabtech Limited Chronic Urticaria Or Hives Drug Product Offered

13.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mabtech Limited Main Business Overview

13.8.5 Mabtech Limited Latest Developments

13.9 Merck & Co., Inc.

13.9.1 Merck & Co., Inc. Company Information

13.9.2 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offered

13.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Merck & Co., Inc. Main Business Overview

13.9.5 Merck & Co., Inc. Latest Developments

13.10 Mycenax Biotech Inc.

13.10.1 Mycenax Biotech Inc. Company Information

13.10.2 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offered

13.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mycenax Biotech Inc. Main Business Overview

13.10.5 Mycenax Biotech Inc. Latest Developments

13.11 Novartis AG

13.11.1 Novartis AG Company Information

13.11.2 Novartis AG Chronic Urticaria Or Hives Drug Product Offered

13.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Novartis AG Main Business Overview

13.11.5 Novartis AG Latest Developments

13.12 Panacea Biotec Limited

13.12.1 Panacea Biotec Limited Company Information

13.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offered

13.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Panacea Biotec Limited Main Business Overview

13.12.5 Panacea Biotec Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of GDC-0853

Table 4. Major Players of GSK-2646264

Table 5. Major Players of BF-Derm-1

Table 6. Major Players of Bilastine

Table 7. Major Players of Others

Table 8. Global Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

Table 10. Global Chronic Urticaria Or Hives Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Chronic Urticaria Or Hives Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Table 15. Global Chronic Urticaria Or Hives Drug Revenue by Application (2017-2022)

Table 16. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Chronic Urticaria Or Hives Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Chronic Urticaria Or Hives Drug Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2020-2022)

Table 20. Global Chronic Urticaria Or Hives Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Chronic Urticaria Or Hives Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution and Sales Area

Table 24. Players Chronic Urticaria Or Hives Drug Products Offered

Table 25. Chronic Urticaria Or Hives Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Chronic Urticaria Or Hives Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Chronic Urticaria Or Hives Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Chronic Urticaria Or Hives Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Chronic Urticaria Or Hives Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Chronic Urticaria Or Hives Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Chronic Urticaria Or Hives Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Chronic Urticaria Or Hives Drug Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Chronic Urticaria Or Hives Drug

Table 69. Key Market Challenges & Risks of Chronic Urticaria Or Hives Drug

Table 70. Key Industry Trends of Chronic Urticaria Or Hives Drug

Table 71. Chronic Urticaria Or Hives Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Chronic Urticaria Or Hives Drug Distributors List

Table 74. Chronic Urticaria Or Hives Drug Customer List

Table 75. Global Chronic Urticaria Or Hives Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Chronic Urticaria Or Hives Drug Sales Market Forecast by Region

Table 77. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Chronic Urticaria Or Hives Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Chronic Urticaria Or Hives Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Chronic Urticaria Or Hives Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Chronic Urticaria Or Hives Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Chronic Urticaria Or Hives Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. AstraZeneca Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offered

Table 97. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. AstraZeneca Plc Main Business

Table 99. AstraZeneca Plc Latest Developments

Table 100. Biofrontera AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Biofrontera AG Chronic Urticaria Or Hives Drug Product Offered

Table 102. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Biofrontera AG Main Business

Table 104. Biofrontera AG Latest Developments

Table 105. ELORAC, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offered

Table 107. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. ELORAC, Inc. Main Business

Table 109. ELORAC, Inc. Latest Developments

Table 110. Faes Farma, SA Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offered

Table 112. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Faes Farma, SA Main Business

Table 114. Faes Farma, SA Latest Developments

Table 115. Genentech, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offered

Table 117. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Genentech, Inc. Main Business

Table 119. Genentech, Inc. Latest Developments

Table 120. GlaxoSmithKline Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offered

Table 122. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. GlaxoSmithKline Plc Main Business

Table 124. GlaxoSmithKline Plc Latest Developments

Table 125. J Uriach Y Compania, S.A. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offered

Table 127. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. J Uriach Y Compania, S.A. Main Business

Table 129. J Uriach Y Compania, S.A. Latest Developments

Table 130. Mabtech Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Mabtech Limited Chronic Urticaria Or Hives Drug Product Offered

Table 132. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Mabtech Limited Main Business

Table 134. Mabtech Limited Latest Developments

Table 135. Merck & Co., Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offered

Table 137. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Merck & Co., Inc. Main Business

Table 139. Merck & Co., Inc. Latest Developments

Table 140. Mycenax Biotech Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offered

Table 142. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Mycenax Biotech Inc. Main Business

Table 144. Mycenax Biotech Inc. Latest Developments

Table 145. Novartis AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Novartis AG Chronic Urticaria Or Hives Drug Product Offered

Table 147. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Novartis AG Main Business

Table 149. Novartis AG Latest Developments

Table 150. Panacea Biotec Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offered

Table 152. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Panacea Biotec Limited Main Business

Table 154. Panacea Biotec Limited Latest Developments

List of Figures

Figure 1. Picture of Chronic Urticaria Or Hives Drug

Figure 2. Chronic Urticaria Or Hives Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chronic Urticaria Or Hives Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Chronic Urticaria Or Hives Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chronic Urticaria Or Hives Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of GDC-0853

Figure 10. Product Picture of GSK-2646264

Figure 11. Product Picture of BF-Derm-1

Figure 12. Product Picture of Bilastine

Figure 13. Product Picture of Others

Figure 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2021

Figure 15. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2017-2022)

Figure 16. Chronic Urticaria Or Hives Drug Consumed in Clinic

Figure 17. Global Chronic Urticaria Or Hives Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Chronic Urticaria Or Hives Drug Consumed in Hospital

Figure 19. Global Chronic Urticaria Or Hives Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Chronic Urticaria Or Hives Drug Consumed in Others

Figure 21. Global Chronic Urticaria Or Hives Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application in 2021

Figure 24. Chronic Urticaria Or Hives Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company in 2021

Figure 26. Global Chronic Urticaria Or Hives Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Chronic Urticaria Or Hives Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Chronic Urticaria Or Hives Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Chronic Urticaria Or Hives Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Chronic Urticaria Or Hives Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Chronic Urticaria Or Hives Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Chronic Urticaria Or Hives Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Chronic Urticaria Or Hives Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2021

Figure 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2021

Figure 40. United States Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region in 2021

Figure 45. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Regions in 2021

Figure 46. China Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2021

Figure 53. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2021

Figure 54. Germany Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Chronic Urticaria Or Hives Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2021

Figure 67. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug

Figure 68. Industry Chain Structure of Chronic Urticaria Or Hives Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles